We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Innovative Catheter System Treats Atrial Arrhythmias

By HospiMedica International staff writers
Posted on 22 Jun 2011
An innovative temperature-sensing saline-irrigated radio frequency (RF) ablation catheter enables lesion control, improving patient outcomes. More...


The Tempasure cardiac ablation catheter system is designed for better outcomes in patients by reducing overall procedure time and increasing therapeutic effectiveness, while avoiding rare but serious adverse events that can occur with current technologies. The system's novel passive sensing microwave radiometry technology allows the electrophysiologist to measure the temperature of cardiac tissue during the ablation procedure, providing real-time information that enables proper energy delivery and lesion control. The technology thus allows safe and effective automatic RF power titration or "temperature mode" irrigated ablation.

The cardiac ablation catheter system continuously measures temperature at three millimeters depth below the heart wall surface, using a proprietary microwave radiometry system called Veritas technology; this is especially useful in left-sided procedures. The new radiometry technology offers real-time safe temperature control during ablations and in the near term promises automatic titration of RF power to create consistent, deep, and wide lesions in left-sided ablation procedures. The Tempasure cardiac ablation catheter system is a product of Advanced Cardiac Therapeutics (Laguna Beach, CA, USA), and has received the European Community (EC) marking of approval.

"We are very pleased that the Tempasure temperature-sensing ablation catheter is now cleared for use in countries that recognize CE mark," said Peter van der Sluis, CEO of Advanced Cardiac Therapeutics. "We look forward to bringing the Tempasure system to patients and physicians in Europe later this year."

Cardiac catheter ablation procedures are used to treat a variety of cardiac arrhythmias including atrial fibrillation (AF) and atrial flutter. The procedures involve advancing a catheter into the heart and selectively ablating certain areas of tissue in order to prevent the spread of electrical signals that give rise to the arrhythmia. The temperature of the tissue during ablation is critical; lower temperatures are ineffective, and temperatures that are too high can result in dangerous over-heating. Saline irrigation ensures that lesions are created safely and are effective deeper inside the cardiac tissue; however, the inclusion of irrigation negates the effectiveness of conventional thermometry.

Related Links:
Advanced Cardiac Therapeutics


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.